Natalie Sacks, Chief Medical Officer at ADURO BIOTECH, INC. (ADRO), sold 3,028 shares at $6.50 ($20K) on 2018-09-13, disclosed to the SEC on 2018-09-14.
Open-market sale of $20k ADRO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HARP | SELL | 2020-04-17 | $18K | — | Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |